Scarica l'app Stockscreener
624.19
2.77%
-17.75
Dopo l'orario di chiusura:
624.19
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$641.94
Aprire:
$647.01
Volume 24 ore:
816.26K
Relative Volume:
1.30
Capitalizzazione di mercato:
$50.20B
Reddito:
$4.04B
Utile/perdita netta:
$985.66M
Rapporto P/E:
51.97
EPS:
12.01
Flusso di cassa netto:
$774.34M
1 W Prestazione:
+9.11%
1M Prestazione:
+14.11%
6M Prestazione:
+35.53%
1 anno Prestazione:
+32.98%
Intervallo 1D:
$623.40
$647.25
Intervallo di 1 settimana:
$527.81
$688.12
Portata 52W:
$356.14
$688.12
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Confronta IDXX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
624.19 | 51.36B | 4.04B | 985.66M | 774.34M | 12.01 |
|
TMO
Thermo Fisher Scientific Inc
|
448.94 | 176.13B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
195.17 | 142.52B | 24.01B | 3.41B | 4.86B | 4.70 |
|
A
Agilent Technologies Inc
|
113.23 | 32.64B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
177.49 | 31.27B | 15.50B | 1.33B | 2.16B | 7.34 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2025 Earnings Call Transcript - Insider Monkey
Why a Company You’ve Never Heard of Is One of the Best Nasdaq-100 Stocks of the Year - inkl
IDEXX strengthens competitive edge in veterinary diagnostics - MarketScreener
IDEXX Laboratories stock price target raised to $785 from $625 at Jefferies - Investing.com India
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for IDEXX Laboratories (NASDAQ:IDXX) Stock - MarketBeat
Is the Market Bullish or Bearish on IDEXX Laboratories? - 富途牛牛
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $626 to $785 - 富途牛牛
Tesla, Delta Air, IDEXX Laboratories And More On CNBC's 'Final Trades' - Benzinga
IDXX Surpasses Analyst Target Price of $558.30 - AInvest
Axon Enterprise, Berkshire Hathaway, Idexx Laboratories - TradingView
IDEXX Laboratories Inc (IDXX) Q2 2025 Earnings Call Highlights: Strong Revenue and EPS Growth ... - Yahoo Finance
IDEXX Laboratories Stock Price, Quotes and Forecasts | NASDAQ:IDXX - Benzinga
Idexx: Q2 Earnings Snapshot - Norwalk Hour
IDEXX Laboratories Inc (IDXX) Q2 2025 Earnings Call Highlights: Strong Revenue and EPS Growth ... By GuruFocus - Investing.com Canada
IDEXX Laboratories Reports Strong Q2 2025 Results - TipRanks
IDEXX Laboratories Soars: A New Benchmark for Animal Health Diagnostics - FinancialContent
IDEXX Laboratories' Price Target Raised to $675 by JP Morgan, Maintains Overweight Rating - AInvest
JPMorgan Boosts Idexx Laboratories' Price Target to $675, Maintains Overweight Rating - AInvest
IDEXX Laboratories Surges on Raised Revenue and Profit Forecasts, Analysts Mixed on One-Year Price Target - AInvest
Stifel Raises Idexx Laboratories Price Target to $640, Keeps Hold Rating - AInvest
Research Alert: CFRA Maintains Buy Opinion On Shares Of Idexx Laboratories, Inc. - 富途牛牛
IDEXX Laboratories Surges on Price Target Adjustments and New Board Member - timothysykes.com
IDEXX Labs Stock Sparks Interest: Analyzing Market Buzz - timothysykes.com
IDEXX LABORATORIES INC /DE SEC 10-Q Report - TradingView
U.S. Indexes Moved Upward Monday; IDEXX Laboratories Led Increases - Barron's
How A 'Puppy Boom' Drove This Company's Beat-And-Raise - Investor's Business Daily
IDEXX Laboratories Stock: Ready for a Breakout? - StocksToTrade
Idexx's Innovation Is on Display with Introduction of InVue Platform - Morningstar
IDEXX Laboratories (IDXX) Boosts 2025 Earnings and Revenue Forecasts - GuruFocus
Is Now a Good Time to Reenter IDEXX Laboratories Inc.Low Risk High Return Opportunities Identified - metal.it
IDEXX Surge: Time to Dive In? - timothysykes.com
Palantir, IDEXX Lead Market Cap Stock Movers on Monday - Investing.com
Idexx Laboratories Shares Rise After 2Q Earnings, Revenue Beat Expectations - 富途牛牛
Here's How Much $1000 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today - Benzinga
IDEXX Laboratories Stock Climbs Amidst Analyst’s Optimistic Price Target Revisions - StocksToTrade
Wayfair, CommScope Holding, Steelcase, IDEXX Laboratories And Other Big Stocks Moving Higher On Monday - Benzinga
IDEXX (IDXX) Shares Surge on Raised Revenue and Profit Forecasts - GuruFocus
IDEXX Surpasses Earnings Expectations, Justifying Premium ValuationIDEXX Laboratories (NASDAQ:IDXX) - Benzinga
Idexx Laboratories Leads S&P 500 Gainers, ON Semiconductor Tumbles - AInvest
Excellent Execution Drove IDEXX Laboratories (IDXX) Shares Amid Macro Challenges - MSN
Idexx Laboratories (IDXX) Shares Soar Over 21% - GuruFocus
IDEXX rises on upgraded guidance fueled by inVue Dx demand - Seeking Alpha
IDEXX Stock Up on Q2 Earnings & Revenue Beat, Margins Expand - TradingView
IDEXX Laboratories Lays Out Higher Forecasts After Strong Quarter - Finimize
Idexx Laboratories stock hits 52-week high at $659.14 By Investing.com - Investing.com Canada
Earnings call transcript: IDEXX Labs beats Q2 2025 expectations, stock surges - Investing.com UK
How Idexx Laboratories Is Riding The 'Puppy Boom' To New Highs - inkl
Axsome Therapeutics, Wayfair, IDEXX Laboratories - TradingView
Earnings Summary: IDEXX Q2 2025 profit rises on higher revenues - AlphaStreet
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):